A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking

A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking

Abstract A novel infectious disease, caused by 2019 Novel Coronavirus (2019-nCoV) is responsible for the recent outbreak of severe respiratory disease. The 2019-nCoV spread rapidly and reaching epidemic proportions in many countries of the world. ACE2 was identified as a key receptor for 2019-nCoV i...

Full description

Bibliographic Details
Main Authors: Zahra Sadat Aghili, Seyed Abbas Mirzaei, Mehdi Banitalebi-Dehkordi
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Journal of Biological Research - Thessaloniki
Subjects:
ACE2
Drug delivery
Nanoparticles
2019-nCoV
RBC hitchhiking
Online Access:https://doi.org/10.1186/s40709-020-00129-y

Internet

https://doi.org/10.1186/s40709-020-00129-y

Similar Items